HB 3127 protects Oklahoma medical marijuana patients and caregivers from discrimination in employment, public assistance, and firearm ownership. It prohibits employers from refusing to hire, firing, or penalizing individuals solely for being a licensed medical marijuana user, and bars denial of Medicaid, SNAP, or firearm rights based on that status. However, the bill mandates a "zero-tolerance" policy for safety-sensitive jobs (like operating vehicles, handling hazardous materials, or direct patient care), allowing employers to enforce drug testing and discipline for marijuana use at work. Employers may still maintain written drug testing policies under state standards, but cannot deny employment based solely on medical marijuana license status or a positive test if the user is licensed and not impaired at work.
HB 3901 establishes a pilot program for psychological autopsies in Oklahoma, which investigate ambiguous deaths (like suicides) to reconstruct a deceased person's mental state and influences. The Commissioner of Health must appoint a full-time psychological autopsy examiner who will submit annual progress reports and coordinate with mental health and medical examiner offices. The pilot runs until November 1, 2031, with a recommendation for permanency or termination. Its goal is to use data from these reviews to inform suicide prevention efforts, without changing existing laws or creating new obligations for individuals.
SJR 38 proposes a constitutional amendment requiring the Tobacco Settlement Endowment Trust Fund to divest 5% of its assets annually (by November 1) and deposit the proceeds into the Health Care Enhancement Fund. This affects the trust fund, which manages Oklahoma's tobacco settlement funds, and directs the Legislature to appropriate these funds for health-related purposes like medical care and prevention programs. The amendment does not change existing trust fund investments but mandates a fixed annual transfer to support health initiatives at the Legislature's discretion.
SB 1447 prohibits the Oklahoma Employees Insurance Plan from awarding contracts to pharmacy benefits managers (PBMs) that have settled lawsuits, been fined, or faced judgments exceeding $4 million in the past five years. The bill requires that state contract evaluations must favor PBMs headquartered in Oklahoma for at least one year and disfavor PBMs with corporate ties to health insurers, retail pharmacies, specialty pharmacies, mail-order pharmacies, or drug manufacturers. Contracted PBMs must also certify compliance with Oklahoma’s health information laws and maintain SOC 2 Type 2 security certification. The law takes effect November 1, 2026.
SB 2043 repeals Section 2-1101 of Oklahoma's Uniform Controlled Dangerous Substances Act, which previously provided legal protections for harm-reduction services. This change directly affects organizations and programs offering services like needle exchanges or overdose prevention, removing their statutory immunity. The bill also amends definitions in Sections 2-101 and 2-101.1 to update language about drug paraphernalia and eliminate related protections. It declares an emergency to take effect immediately upon enactment. This is a procedural legislative change removing existing legal safeguards for harm-reduction initiatives.
This bill prohibits the land application, sale, or distribution of biosolids (wastewater treatment byproducts) containing perfluoroalkyl substances (PFAS) on agricultural land in Oklahoma. It specifically bans materials like sewage sludge, compost made with sludge, or fertilizers derived from sludge, with limited exemptions for food-processing byproducts (e.g., spent grain from brewing) and animal manure. The Oklahoma Department of Environmental Quality and Agriculture must enforce the ban, develop PFAS remediation plans for affected farmers, and submit reports by February 2027 detailing implementation and costs. The law targets PFAS contamination risks in soil and crops while allowing alternative agricultural materials to be used.
SB 1644 would require Oklahoma's health department to add alpha-gal syndrome (AGS) to the official list of reportable diseases, meaning doctors, nurses, and clinical laboratories must report diagnosed cases to the state health department. AGS is a condition causing allergic reactions to red meat and other animal products, which currently lacks formal tracking in Oklahoma. The bill updates existing health reporting laws to include AGS and makes the language gender-neutral. It would take effect on November 1, 2026.
SB 1485 requires Oklahoma medical examiners to conduct specific investigations within 48 hours for unexplained infant or child deaths (including SIDS, SUID, and SDY) and sudden cardiac deaths in young people (SADS). The bill mandates autopsies, toxicology tests, medical record reviews (including immunization data from the past 90 days), and interviews with caregivers. Medical examiners must document findings, report cases to the CDC’s national SUID/SDY registry, and submit reports to the State Department of Health and Child Death Review Board. This applies directly to medical examiners, health departments, and families of affected infants, children, and young people.
SB 1663 requires all health insurance plans in Oklahoma to cover specific cooling systems (like scalp or hand cooling devices) used during chemotherapy to prevent side effects such as hair loss or nerve issues. This directly affects chemotherapy patients who use these devices and insurers who must provide coverage without applying annual deductibles, co-pays, or coinsurance. The bill also ensures this coverage isn’t subject to standard plan limits and includes limited exceptions for health savings accounts related to preventive care. It aims to reduce out-of-pocket costs for a specific, medically necessary treatment. The bill is designated as an emergency, meaning it takes effect immediately upon approval.
HB 4294 requires health insurers in Oklahoma to provide equal coverage for epilepsy as for other conditions, prohibiting termination or non-renewal of policies solely due to an epilepsy diagnosis. It mandates coverage for seizure prevention devices, surgeries, or medical procedures prescribed by an epilepsy specialist when medically necessary to reduce SUDEP (sudden unexpected death in epilepsy) risk. The law applies to all individual and group health insurance plans covering medical/surgical benefits and takes effect November 1, 2026. This directly affects epilepsy patients and insurers offering such coverage in Oklahoma.
